Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiomyopathy
Pharma
ESC: Cytokinetics data is first to demonstrate benefit for nHCM
New Cytokinetics data showed first-of-its-kind benefits in a rare heart condition, potentially teeing the company up for a watershed FDA approval.
Donavyn Coffey
Aug 28, 2026 5:50am
AstraZeneca, Ionis shares slide with ATTR-CM trial failure
Jul 9, 2026 11:36am
Cytokinetics scores with Myqorzo in key cardiomyopathy trial
May 5, 2026 8:00am
BridgeBio CEO shrugs off recent Attruby pricing pressure fears
Feb 25, 2026 2:30pm
Trial win for BMS sets up Camzyos for pediatric expansion
Jan 12, 2026 10:25am
Cytokinetics scores its first FDA nod with Myqorzo approval
Dec 22, 2025 12:05pm
